The increasing prevalence of cancer and other chronic diseases and the growing cases of COVID-19 across various regions are the factors supporting the market proliferation. According to the World Cancer Research Fund and American Institute for Cancer, in 2020, ~18.1 million cancer cases were recorded worldwide, including 9.3 million cases in men and 8.8 million cases in women. Various types of monoclonal antibodies are being adopted for the treatment of different cancer types, and a few of these products are still in phases 2 and 3 clinical trials. Thus, the rising prevalence of chronic diseases has raised the demand for monoclonal antibodies across the world.

The List of Companies -
1. Novartis AG
2. Pfizer Inc.
3. GlaxoSmithKline plc
4. Amgen, Inc
5. Daiichi Sankyo Company, Limited
6. F. Hoffmann-La Roche AG
7. AstraZeneca
8. Elli Lilly and Company
9. Bayer AG
10. Bristol-Myers Squibb Company

The monoclonal antibodies market is segmented on the basis of source, production method, indication application, and end-user. Based on source, the market is segmented into murine, chimeric, human, and humanized. The human segment is estimated to account for the largest market share during 2021-2028. The market growth of this segment is attributed to the rise on account of the integration of human monoclonal antibodies for the treatment of various kinds of infectious diseases. For instance, Regeneron launched FDA approved antibody cocktail casirivimab and imdevimab together for use in COVID-19. The drug has received Emergency Use Authorization (EUA) from FDA. It is used for the treatment of mild to moderate COVID-19 in adults as well as in pediatric patients at least 12 years of age and weighing at least 40kg. Moreover, an increase in their use in various chronic diseases and employment of advanced genetic engineering technology are among the significant factors driving the market segment's growth
The World Health Organization (WHO), World Cancer Research Fund International, Organization for Economic Co-operation and Development (OECD), Centers for Medicare & Medicaid Services (CMS), US Department of Health and Human Services, National Institute of Health (NIH), and American Institute of Cancer are among the primary and secondary sources referred to while preparing the report on the monoclonal antibodies market.

By indication, the monoclonal antibodies market is segmented into cancer, autoimmune diseases, inflammatory diseases, infectious disease, microbial disease, and others. The cancer segment is expected to dominate the market during the forecast period Advancements related to the therapeutic application of monoclonal antibodies have enabled their successful implementation in the treatments of various cancer types, such as breast cancer, lung cancer, and colon cancer. Drugs based on these antibodies help in flagging cancer cells, triggering cell-membrane destruction, blocking immune system inhibitors, and so on. The FDA, in June 2020, approved two drugs-olaparib and rucaparib-for the treatment of prostate cancer. The drug is especially effective among men with prostate cancer conditions that have spread or metastasized and has stopped responding to standard hormone treatments, i.e., castration-resistant disease condition.

Market Analysis and Insights:
Monoclonal Antibodies Market report elaborates the market size, market characteristics, and market growth of the Monoclonal Antibodies industry, and breaks down according to the type, application, and consumption space of Monoclonal Antibodies. The report also conducted a PESTEL analysis of the industry to check the most influencing factors and entry barriers of the industry.

Some of the key queries answered in this report:
• -What can we estimate about the anticipated growth rates and also the Monoclonal Antibodies industry size by 2030?
• -What will happen in the coming existing and emerging markets?
• -Which are the five top players within the Monoclonal Antibodies market?
• -How can the Monoclonal Antibodies market change in the upcoming years?
• -Which product and application will take a share of the Monoclonal Antibodies market?
• -What will be the CAGR and size of the Monoclonal Antibodies market throughout the forecast period?
• -What are the market opportunities and challenges two-faced by the key vendors?
• -Who are the major competitors and what is their strategy?
• -What are the barriers to entry for new players in the market?
• -What would be the upcoming Monoclonal Antibodies market behaviour forecast with trends, challenges, and drivers for development?
• -What business opportunities and dangers are faced by vendors in the market?
• -Which would be Monoclonal Antibodies industry opportunities and challenges have faced by most vendors in the market?
• -What will be the outcomes of this market SWOT five forces analysis?

Customize Your Report:
Don't miss out on the chance to talk to our analyst and know more insights concerning this market report. Our analysts can also assist you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with custom-made information during a short quantity of your time.

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 By Source
1.3.2 By Production Method
1.3.3 By Indication
1.3.4 By Application
1.3.5 By End-User
1.3.6 By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer and Other Chronic Diseases
5.1.2 mABs Uptake Proves to be Effective During Pandemic Outbreak
5.2 Market Restraints
5.2.1 Low Awareness, Accessibility, and High Cost
5.3 Market Opportunities
5.3.1 Cost-effective Advanced Technology for Developing mABs Presents Billion-Dollar Opportunity
5.4 Future Trends
5.4.1 Strategic Research Collaborations
5.5 Impact Analysis
6. Global Analysis
6.1 Global Revenue Forecast and Analysis
6.2 Global By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Revenue and Forecasts To 2028- by Source
7.1 Overview
7.2 Market, By Source, 2021 & 2028 (%)
7.3 Murine
7.3.1 Overview
7.3.2 Revenue and Forecasts to 2028 (US$ Million)
7.4 Chimeric
7.4.1 Overview
7.4.2 Revenue and Forecasts to 2028 (US$ Million)
7.5 Humanized
7.5.1 Overview
7.5.2 Revenue and Forecasts to 2028 (US$ Million)
7.6 Human
7.6.1 Overview
7.6.2 Revenue and Forecasts to 2028 (US$ Million)
8. Revenue and Forecasts To 2028 - Production Method
8.1 Overview
8.2 Share by Production Method Segment - 2021 & 2028 (%)
8.3 In-Vivo
8.3.1 Overview
8.3.2 In-Vivo: Revenue and Forecast to 2028 (US$ Million)
8.4 In-Vitro
8.4.1 Overview
8.4.2 In-Vitro: Revenue and Forecast to 2028 (US$ Million)
9. Revenue and Forecasts To 2028 - Indication

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.

The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.

We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email: [email protected]